OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer. Arai J, Niikura R, Hayakawa Y, Aoki T, et al. Gut 2021 Aug 3. pii: gutjnl-2021-325551. doi: 10.1136/gutjnl-2021-325551.

Read + Share

Amedeo Smart

Independent Medical Education

Arai J, Niikura R, Hayakawa Y, Aoki T, et al. OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer. Gut 2021 Aug 3. pii: gutjnl-2021-325551. doi: 10.1136/gutjnl-2021-325551.
PMID: 34344784